Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
TWTR Twitter Inc
WEX WEX Inc
BBY Best Buy Co Inc
PLX Protalix Biotherapeutics Inc
JPM JPMorgan Chase & Co
KMB Kimberly-Clark Corp
PWR Quanta Services Inc
ONLI Online Redefined Inc
SLDB Solid Biosciences Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Ocugen, Inc., formerly Histogenics Corporation is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. The Company offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The Company is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The Company is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100).

Closing Price
$8.75
Day's Change
0.52 (6.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.80
Day's Low
8.01
Volume
(Light)
Volume:
42,018,297

10-day average volume:
112,957,275
42,018,297
  • Prev Close
    8.23
  • Today's Open
    8.25
  • Day's Range
    8.01-8.80
  • Avg Vol (10-day)
    113.0M
  • Last (time)
    4:00p ET 05/14/21
  • Last (size)
    100
  • 52-Wk Range
    0.17 - 18.77
    LowHigh
  • (06/01/20 - 02/08/21)
    5,047.06%
  • 262.4%
  • Market Cap
    1.7B
  • Shares Outstanding
    198.2M
  • -0.33
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.5
  • 8.11
  • (% of float 04/30/21)
    19.17

Latest News

May 07, 2021
7:30 am ET
Globe Newswire
6:45 am ET
Accesswire
May 06, 2021
8:54 am ET
Globe Newswire
May 03, 2021
4:35 pm ET
Globe Newswire
10:51 am ET
MarketWatch
7:30 am ET
Globe Newswire
April 28, 2021
8:00 am ET
Globe Newswire
April 23, 2021
3:00 pm ET
Globe Newswire
8:45 am ET
PR Newswire
April 21, 2021
8:49 am ET
Globe Newswire
April 14, 2021
11:40 am ET
Globe Newswire
March 29, 2021
8:54 am ET
Globe Newswire
March 18, 2021
7:30 am ET
Globe Newswire
6:30 am ET
Accesswire
March 12, 2021
5:45 pm ET
Globe Newswire
March 08, 2021
2:50 pm ET
Globe Newswire
March 03, 2021
8:20 am ET
MarketWatch
8:10 am ET
MarketWatch
8:09 am ET
MarketWatch
8:07 am ET
MarketWatch
8:06 am ET
MarketWatch
8:00 am ET
Globe Newswire
February 23, 2021
7:30 am ET
Globe Newswire
February 08, 2021
4:31 pm ET
MarketWatch
1:05 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.